Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

One Year on Mounjaro: 35kg Lost, Life Looks Different

Someone shared a short update saying they used Mounjaro for a year and went from 115 kg down to 80 kg. That’s the news: a one-year weight change tied to a drug called Mounjaro, posted as a personal result. It’s a single person’s report, not a clinical trial or scientific paper. Mounjaro is the brand name for tirzepatide. In plain terms, it’s a prescription medicine that acts like hormones your gut uses to help control appetite and blood sugar. It tells your brain you’re less hungry and can slow how quickly your stomach empties, so you feel full longer. Doctors prescribe it mostly for people with type 2 diabetes, though it’s also been studied and used to help with weight loss. What this snippet shows is an individual’s experience — a big drop from 115 kg to 80 kg over about a year. That’s a sizable loss (about 35 kg). But it’s just one person’s result. Clinical trials of tirzepatide have shown meaningful weight loss on average for groups of patients, and people in those trials often see substantial drops, but outcomes vary. This post doesn’t tell us about dose, other treatments, diet or exercise changes, side effects, or medical supervision, so we can’t say how typical or safe this result is. Why it matters is straightforward: significant weight loss can improve health markers like blood sugar, blood pressure, and joint stress for many people. If drugs like Mounjaro can help people lose weight when diet and exercise alone haven’t worked, that could change how obesity and type 2 diabetes are treated. People struggling with weight or diabetes might see this as hopeful evidence that medical therapies can produce real results. There are important caveats and risks. Prescription medications like Mounjaro have side effects — common ones include nausea, diarrhea, or constipation — and less common but more serious risks exist. They should be used under a doctor’s supervision. These drugs may not be appropriate for people with certain medical histories, and stopping the medication can lead to weight regain unless lifestyle changes are maintained. Also, single social-media posts can be exaggerated or missing context; they don’t replace controlled studies. Bottom line: a one-year before-and-after post suggests tirzepatide helped someone lose a lot of weight, but it’s an individual story. Talk with a doctor to understand if such a treatment is safe and likely to help you.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE